ARVO Statement:
As the world’s largest eye and vision research community, the Association for Research in Vision and Ophthalmology (ARVO) believes strongly in advocating for open, inclusive and accessible science as well as science-informed policy. Through its mission to advance research worldwide into understanding the visual system and preventing, treating and curing its disorders, ARVO affirms the critical need for science to guide policy and provide necessary guidance to keep the public informed. ARVO stands in support of the scientific community and the collaboration of researchers worldwide.
Advocacy Updates
- June 7, 2020 ARVO statement on social injustice
COVID-19
- Visit the AAO Coronavirus and Eye Care resources
- June 24, 2020 ARVO endorses The Research Investment to Secure the Economy (RISE) Act (H.R. 7308)
- May 21, 2020 Multisociety letter on supplemental funding for VA to support COVID-19 research efforts
- May 4, 2020 ARVO endorses Markey-Tillis Senate Letter supporting COVID-19 research related relief
- April 19, 2020 ARVO endorses DeGette-Upton Dear Colleague Letter supporting COVID-19 research related relief
- March 25, 2020 Multisociety letter on COVID-19 and restrictions on fetal tissue
Funding
- July 7, 2020 Ad Hoc Group for Medical Research Statement on Draft House FY 21 Labor-HHS Appropriations Bill
- May 22, 2020 ARVO testimony supporting increased FY2021 NIH, NEI funding to Senate Committee on Appropriations
- March 21, 2020 ARVO testimony supporting increased FY2021 NIH, NEI funding to House Committee on Appropriations
- Feb. 24, 2020 CDC Vision and Health FY2021 appropriations to the House and Senate
- Feb. 10, 2020 Multisociety letter on FY2021 NIH funding
- Dec. 4, 2019 Multisociety letter on FY2020 appropriations
- Oct. 24, 2019 Multisociety letter on FY2020 NIH funding
- April 1, 2020 ARVO among organizational supporters of Protecting Cures Act of 2020 (H.R. 6417)
- June 1, 2019 ARVO testimony supporting increased FY2020 NIH, NEI funding to Senate Committee on Appropriations
- Mar. 28, 2018 Research!America letter thanking Congress for boost to research spending
- Feb. 15, 2018 Letter to secure robust investments in science
- Aug. 21, 2017 Cuts to NIH, indirect costs
- April 26, 2018 ARVO testimony for FY19 NIH, NEI funding to House Appropriations Committee
Fetal tissue
- July 11, 2019 Letter to HHS Secretary on fetal tissue ban
- June 12, 2019 Pocan Amendment on fetal tissue ban
- Sept. 16, 2019 Letter to HHS Secretary on fetal tissue research
Animals in research
- June 27, 2019 Letter on restriction of canines
- May 16, 2018 Regulatory relief for animal research facilities
Research enterprise
- July 13, 2020 Multisociety letter opposing Student and Exchange Visitor Program (SEVP) modifications
- June 19, 2020 Multisociety letter to HHS Secretary and Administrator Berma on Medicare Part B covered drugs
- May 1, 2020 Multisociety letter to Reps. DeLauro and Cole for Eye Bonds support in FY2021 appropriations
- Jan. 10, 2020 RFC Draft NIH Policy for Data Management and Sharing and Supplemental Draft Guidance
- Sept. 4, 2019 Multisociety letter on foreign influence
- Nov. 12, 2018 NIH registration and results reporting standards for prospective basic science studies involving human participants
- May 24, 2018 Changes to U.S. visa application
- April 23, 2018 Revision of new NIH clinical trial definition
- Nov. 22, 2017 March for Science letter on elimination of graduate student tax credit
- Nov. 15, 2017 AAAS letter on repeal of graduate student tax credit
- Oct. 27, 2017 NIH redefinition of clinical trial
- Oct. 17, 2017 Revised travel ban
- Aug. 16, 2017 New NIH clinical trial definition
- July 11, 2017 Sequestration relief
- May 24, 2017 FY 2018 RandD budget cuts
- May 18, 2017 Additional visa questions
- April 25, 2017 Global public support for science
- April 6, 2017 FY 2017 investment in RandD
- Feb. 27, 2017 Federal hiring freeze
- Feb. 24, 2017 ARVO statement supporting the March for Science
- Feb. 1, 2017 Travel ban
- Jan. 31, 2017 Travel ban